The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 25, 2014
Filed:
Aug. 22, 2012
Odile Esther Levy, San Diego, CA (US);
Alain D. Baron, San Diego, CA (US);
Lawrence J. D'souza, San Diego, CA (US);
Mary Erickson, San Diego, CA (US);
Soumitra G. Ghosh, San Diego, CA (US);
Michael R. Hanley, San Diego, CA (US);
Samuel Janssen, San Diego, CA (US);
Carolyn M. Jodka, San Diego, CA (US);
Diana Y. Lewis, San Diego, CA (US);
Christine M. Mack, San Diego, CA (US);
David G. Parkes, San Diego, CA (US);
Richard A. Pittner, San Diego, CA (US);
Christopher J. Soares, San Diego, CA (US);
Ved Srivastava, San Diego, CA (US);
Andrew A. Young, San Diego, CA (US);
Thao Le, San Diego, CA (US);
Odile Esther Levy, San Diego, CA (US);
Alain D. Baron, San Diego, CA (US);
Lawrence J. D'Souza, San Diego, CA (US);
Mary Erickson, San Diego, CA (US);
Soumitra G. Ghosh, San Diego, CA (US);
Michael R. Hanley, San Diego, CA (US);
Samuel Janssen, San Diego, CA (US);
Carolyn M. Jodka, San Diego, CA (US);
Diana Y. Lewis, San Diego, CA (US);
Christine M. Mack, San Diego, CA (US);
David G. Parkes, San Diego, CA (US);
Richard A. Pittner, San Diego, CA (US);
Christopher J. Soares, San Diego, CA (US);
Ved Srivastava, San Diego, CA (US);
Andrew A. Young, San Diego, CA (US);
Thao Le, San Diego, CA (US);
AstraZeneca Pharmaceuticals, LP, Wilmington, DE (US);
Amylin Pharmaceuticals, LLC, San Diego, CA (US);
Abstract
The present invention relates generally to novel GIP analogs and GIP hybrid polypeptides with selectable properties, useful as agents for the treatment and prevention of metabolic diseases and disorders, for example those which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, positive inotropic effects, reduction of catabolic effects, slowing of gastric emptying. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, critical care, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.